Search Results 211-220 of 17526 for Liposome

1. Isavuconazonium (intravenous route) - Side effects & uses - Mayo Clinic

   Doxorubicin Hydrochloride Liposome; Elexacaftor; Eliglustat; Elinzanetant; Enasidenib; Encorafenib; Ensartinib; Everolimus; Fedratinib; Finerenone; Fluconazole ...

2. Breast cancer surgery - Doctors & Departments - Mayo Clinic

   Comparative study of liposomal bupivacaine versus paravertebral block for pain control following mastectomy with immediate tissue expander reconstruction.

3. Phase 3 Study to Treat Patients with Soft Tissue Sarcomas - Mayo Clinic

   Prior exposure to >375 mg/m2 of doxorubicin or liposomal doxorubicin. Palliative surgery and/or radiation treatment within 30 days prior to date of ...

4. Clinical trials - Oncology (Medical)

   Oncolytic Adenovirus Coding For TNFa And IL2 (TILT-123) With Pembrolizumab Or Pembrolizumab And Pegylated Liposomal Doxorubicin As Treatment For Ovarian Cancer.

5. First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b - Mayo Clinic

   In Sweden, patients must have received prior treatment with pegylated liposomal doxorubicin or paclitaxel, if not contraindicate. Patients must be willing ...

6. Glecaprevir and pibrentasvir (oral route) - Mayo Clinic

   Doxorubicin Hydrochloride Liposome; Drospirenone; Efavirenz; Elexacaftor; Eltrombopag; Ensartinib; Ethinyl Estradiol; Etonogestrel; Fosphenytoin; Haloperidol ...

7. Clinical trials - Oncology (Medical)

   Oncolytic Adenovirus Coding For TNFa And IL2 (TILT-123) With Pembrolizumab Or Pembrolizumab And Pegylated Liposomal Doxorubicin As Treatment For Ovarian Cancer.

8. Pertuzumab (intravenous route) - Side effects & uses - Mayo Clinic

   Daunorubicin Citrate Liposome; Daunorubicin Liposome; Doxorubicin; Ebola Zaire Vaccine, Live; Epirubicin; Idarubicin; Influenza Virus Vaccine, Live; Pirarubicin ...

9. Clinical trials - Oncology (Medical)

   Oncolytic Adenovirus Coding For TNFa And IL2 (TILT-123) With Pembrolizumab Or Pembrolizumab And Pegylated Liposomal Doxorubicin As Treatment For Ovarian Cancer.

10. Clinical trials - Oncology (Medical)

    Oncolytic Adenovirus Coding For TNFa And IL2 (TILT-123) With Pembrolizumab Or Pembrolizumab And Pegylated Liposomal Doxorubicin As Treatment For Ovarian Cancer.